These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 3160453)

  • 21. Selective targeting of anti-cancer drug and simultaneous image enhancement in solid tumors by arterially administered lipid contrast medium.
    Konno T; Maeda H; Iwai K; Maki S; Tashiro S; Uchida M; Miyauchi Y
    Cancer; 1984 Dec; 54(11):2367-74. PubMed ID: 6093980
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiple hepatic infarction after transcatheter arterial infusion with SMANCS.
    Abe S; Yamasaki T; Nakano K; Yoshikawa I; Tabaru A; Otsuki M
    J Gastroenterol; 2001 Jun; 36(6):415-21. PubMed ID: 11428589
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Arterial administration of oily anticancer agents dissolved in lipiodol fluid in recurrence of hepatoma after hepatic resection and in metastatic liver cancer].
    Ohtsuka N; Konno T
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-2):1351-8. PubMed ID: 2837992
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Histological effect of SMANCS/LPD therapy in renal cell carcinoma].
    Suzuki T; Kobayashi M; Nakamura T; Takahashi O; Imai K; Yamanaka H; Suzuki K; Konno T; Maeda H
    Nihon Gan Chiryo Gakkai Shi; 1987 Oct; 22(9):2210-7. PubMed ID: 2833546
    [No Abstract]   [Full Text] [Related]  

  • 25. [SMANCS/lipiodol].
    Maeda H
    Gan To Kagaku Ryoho; 1994 May; 21(6):907-13. PubMed ID: 8185354
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Tumor selective drug delivery with lipid contrast medium (smancs/lipiodol): sustained antitumor effect, enhanced diagnostic value and quantification of dosage regimen].
    Maeda H; Konno T; Iwai K; Maki S; Tashiro S
    Gan To Kagaku Ryoho; 1984 Apr; 11(4):814-26. PubMed ID: 6326681
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel dosage approach for evaluation of SMANCS [poly-(styrene-co-maleyl-half-n-butylate) - neocarzinostatin] in the treatment of primary hepatocellular carcinoma.
    Seymour LW; Olliff SP; Poole CJ; De Takats PG; Orme R; Ferry DR; Maeda H; Konno T; Kerr DJ
    Int J Oncol; 1998 Jun; 12(6):1217-23. PubMed ID: 9592177
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Arterial infusion chemotherapy with SMAN CS-Lipiodol for hepatocellular carcinoma evaluation of infusion method].
    Takizawa K; Obuchi M; Honda M; Matsuoka S; Shima H; Uchiyama K; Hasebe S; Doai K; Satoh S; Kuniyasu Y
    Gan To Kagaku Ryoho; 1997 Nov; 24(14):2117-22. PubMed ID: 9388522
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Styrene maleic acid neocarzinostatin-transcatheter embolization for hepatocellular carcinoma--third report].
    Hasegawa I; Hirashima N
    Gan To Kagaku Ryoho; 2002 Feb; 29(2):253-9. PubMed ID: 11865632
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Targeted chemotherapy of hepatocellular carcinoma with SMANCS/Lipiodol--how to use SMANCS/Lipiodol].
    Konno T; Tabaru K; Isogai M; Nagamitsu A; Oda T
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():10-8. PubMed ID: 9512681
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SMANCS and polymer-conjugated macromolecular drugs: advantages in cancer chemotherapy.
    Maeda H
    Adv Drug Deliv Rev; 2001 Mar; 46(1-3):169-85. PubMed ID: 11259839
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antitumor activity of orally administered SMANCS, a polymer-conjugated protein drug, in mice bearing various murine tumors.
    Schmitt DA; Kisanuki K; Kimura S; Oka K; Pollard RB; Maeda H; Suzuki F
    Anticancer Res; 1992; 12(6B):2219-24. PubMed ID: 1295469
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Tumor-targeted chemotherapy with lipid contrast medium and macro molecular anticancer agents theoretical considerations and clinical outcome].
    Maeda H; Konno T
    Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 2):773-82. PubMed ID: 2985005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Successful arterial administration therapy of SMANCS for liver metastasis of malignant insulinoma.
    Igarashi H; Ito T; Ogoshi K; Kuroiwa T; Koyanagi S; Arita Y; Sumii T; Nawata H
    Pancreas; 1999 Aug; 19(2):207-10. PubMed ID: 10438170
    [No Abstract]   [Full Text] [Related]  

  • 35. Styrene maleic acid neocarzinostatin treatment for hepatocellular carcinoma.
    Abe S; Otsuki M
    Curr Med Chem Anticancer Agents; 2002 Nov; 2(6):715-26. PubMed ID: 12678722
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Experience with intraarterial infusion of styrene maleic acid neocarzinostatin (SMANCS)-lipiodol in pancreatic cancer.
    Yoshida H; Onda M; Tajiri T; Uchida E; Arima Y; Mamada Y; Yamamoto K; Kaneko M; Terada Y; Kumazaki T
    Hepatogastroenterology; 1999; 46(28):2612-5. PubMed ID: 10522050
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transarterial chemotherapy with zinostatin stimalamer for hepatocellular carcinoma.
    Okusaka T; Okada S; Ishii H; Ikeda M; Nakasuka H; Nagahama H; Iwata R; Furukawa H; Takayasu K; Nakanishi Y; Sakamoto M; Hirohashi S; Yoshimori M
    Oncology; 1998; 55(4):276-83. PubMed ID: 9663415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Targeting cancer chemotherapy using lipiodol as a carrier of anticancer drugs for hepatocellular carcinoma].
    Konno T; Maeda H
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):1043-50. PubMed ID: 2839112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Repeated arterial infusion of zinostatin stimalamer using port for advanced hepatocellular carcinoma].
    Yoshikawa M; Ebara M; Fukuda H; Sugiura N; Saisho H
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():30-3. PubMed ID: 9512684
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Zinostatin stimalamer-transcatheter arterial embolization for hepatocellular carcinoma: a comparison with lipiodol-transcatheter arterial embolization.
    Hirashima N; Sakakibara K; Itazu I; Hirai T; Nemoto A; Matsuura H; Kumada K; Nojiri O; Kano H
    Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-91-S6-96. PubMed ID: 9151922
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.